pGB-REL
(Plasmid
#27277)
-
Depositing Lab
-
Publication
-
Sequence Information
Full plasmid sequence is not available for this item.
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 27277 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepGBT9
- Backbone size w/o insert (bp) 5524
-
Vector typeYeast Expression
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Copy numberHigh Copy
Gene/Insert
-
Gene/Insert nameREL
-
SpeciesH. sapiens (human)
-
Insert Size (bp)927
-
Entrez GeneREL (a.k.a. C-Rel, HIVEN86A, IMD92)
-
Tag
/ Fusion Protein
- GAL4 (aa1-147) (N terminal on backbone)
Cloning Information
- Cloning method Restriction Enzyme
- 5′ cloning site BamHI (not destroyed)
- 3′ cloning site XhoI (not destroyed)
- 5′ sequencing primer Gal4 N-term (Common Sequencing Primers)
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pGB-REL was a gift from Thomas Gilmore (Addgene plasmid # 27277 ; http://n2t.net/addgene:27277 ; RRID:Addgene_27277) -
For your References section:
Deletion analysis and alternative splicing define a transactivation inhibitory domain in human oncoprotein REL. Leeman JR, Weniger MA, Barth TF, Gilmore TD. Oncogene. 2008 Dec 4. 27(53):6770-81. 10.1038/onc.2008.284 PubMed 18695674